# EDGAR Filing Document

**Accession Number:** 0000310354
**File Stem:** 0001437749-25-038746
**Filing Date:** 2025-12
**Character Count:** 22775
**Document Hash:** f45fdc575de53fec8abaa03df1d7ddea
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-25-038746.hdr.sgml**: 20251229

**ACCESSION NUMBER**: 0001437749-25-038746

**CONFORMED SUBMISSION TYPE**: 10-K/A

**PUBLIC DOCUMENT COUNT**: 17

**CONFORMED PERIOD OF REPORT**: 20240630

**FILED AS OF DATE**: 20251229

**DATE AS OF CHANGE**: 20251223

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** STANDEX INTERNATIONAL CORP/DE/
- **CENTRAL INDEX KEY:** 0000310354
- **STANDARD INDUSTRIAL CLASSIFICATION:** REFRIGERATION & SERVICE INDUSTRY MACHINERY [3580]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 310596149
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 10-K/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-07233
- **FILM NUMBER:** 251601955

**BUSINESS ADDRESS:**
- **STREET 1:** 23 KEEWAYDIN DRIVE
- **STREET 2:** SUITE 300
- **CITY:** SALEM
- **STATE:** NH
- **ZIP:** 03079
- **BUSINESS PHONE:** 603-893-9701

**MAIL ADDRESS:**
- **STREET 1:** 23 KEEWAYDIN DRIVE
- **STREET 2:** SUITE 300
- **CITY:** SALEM
- **STATE:** NH
- **ZIP:** 03079

?xml version='1.0' encoding='ASCII'? sxi20251110_10ka.htm

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

(**Amendment No 1)**

**FORM 10-K/A**

**☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

---

| | |
|:---|:---|
| For the fiscal year ended June 30, 2024 | Commission File Number 001-07233 |

---

**STANDEX INTERNATIONAL CORPORATION**

*(Exact name of registrant as specified in its Charter)*

---

| | |
|:---|:---|
| Delaware | 31-0596149 |
| *(State of incorporation)* | *(I.R.S. Employer Identification No.)* |
| 23 KEEWAYDIN DRIVE, Salem, New Hampshire | 03079 |
| *(Address of principal executive offices)* | *(Zip Code)* |

---

(603) 893-9701

*(Registrant*'*s telephone number, including area code)*

SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE

SECURITIES EXCHANGE ACT OF 1934:

---

| | | |
|:---|:---|:---|
| <u>Title of Each Class</u> | <u>Trading Symbol(s)</u> | <u>Name of Each Exchange on Which Registered</u> |
| Common Stock, Par Value $1.50 Per Share | SXI | New York Stock Exchange |

---

Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. **Yes** ☒ **No** ☐

Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. **Yes** ☐ **No** ☒

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. **Yes** ☒ **No** ☐

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein and will not be contained, to the best of Registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☒

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). **Yes** ☒ **No** ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer ☒ | Accelerated filer ☐ | Non-accelerated filer ☐ | Smaller Reporting Company ☐ |
|  |  |  | Emerging growth company ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 USC. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. **YES** ☒ **NO** ☐

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to § 240.10D-1(b). ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). **YES** ☐ **NO** ☒

The aggregate market value of the voting and non-voting common equity held by non-affiliates of the Registrant at the close of business on December 31, 2023 was approximately $1,855,686,511. Registrant's closing price as reported on the New York Stock Exchange for December 31, 2023 was $158.38 per share.

The number of shares of Registrant's Common Stock outstanding on July 31, 2024 was 11,854,539.

DOCUMENTS INCORPORATED BY REFERENCE

------

STANDEX INTERNATIONAL CORPORATION

2024 ANNUAL REPORT ON FORM 10-K/A

EXPLANATORY NOTE

Standex International Corporation (the "Company") is filing this Amendment No. 1 on Form 10-K/A (this "Form 10-K/A"), which amends and supplements our Annual Report on Form 10-K ("the Original Filing") for the fiscal year ended June 30, 2024, which was filed with the Securities and Exchange Commission (the "SEC") on August 2, 2024. The Company is filing this Form 10-K/A solely for the purpose of amending the Exhibit List to include the SEC mandated Compensation Clawback Policy which was inadvertently excluded in the previously filed 10-K Report. The Compensation Clawback Policy was originally adopted on August 15, 2023 and has been publicly available under the "Investors" section of the Company's website. Accordingly, we are filing this Amendment No. 1 to the Form 10-K to include said Exhibit.

This Amendment No. 1 does not update or amend any other items in the Original Filing in any way other than as described in the preceding paragraph, and the Original Filing, as amended by this Amendment No. 1, continues to be applicable as of the date of the Original Filing. Accordingly, this Amendment No. 1 should be read in conjunction with the Original Filing and the Company's other filings with the Securities and Exchange Commission.

**PART IV**

**ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES**

The following exhibits are filed as part of this Amendment No. 1 to the Company's Annual Report on Form 10-K.

------

**INDEX TO EXHIBITS**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | **Incorporated** | **Incorporated** | |
| | | **by Reference** | **by Reference** | |
| <br>**Exhibit**<br>**Number** | <br>**Exhibit Description** | **Form** | **Date** | <br>**Filed**<br>**Herewith** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;31.1 | [Certification of the Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex_899718.htm) |  |  | X |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;31.2 | [Certification of the Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex_899719.htm) |  |  | X |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;97. | [Compensation Clawback Policy](ex_886113.htm) |  |  | X |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |  |  |  |

---

------

**SIGNATURES**

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, Standex International Corporation has duly caused this Amendment No. 1 to the Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized, on December 23, 2025.

---

| |
|:---|
| STANDEX INTERNATIONAL CORPORATION |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Registrant) |
| /s/ ADEMIR SARCEVIC |
| Ademir Sarcevic |
| Vice President/Chief Financial Officer |

---

Deloitte & Touche LLP

115 Federal Street, Winthrop Center

Boston, MA 02210-1894 USA

Auditor Firm Id: 34

**END OF FORM 10-K/A**

## Exhibit 31.1

**EXHIBIT 31.1**

**<u>CERTIFICATION</u>**

I, David Dunbar, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Standex International Corporation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

Date: December 23, 2025

*/s/ David Dunbar*

______________________________

David Dunbar

President/Chief Executive Officer

## Exhibit 31.2

**EXHIBIT 31.2**

**<u>CERTIFICATION</u>**

I, Ademir Sarcevic, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Standex International Corporation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

Date: December 23, 2025

*/s/ Ademir Sarcevic*

______________________________

Ademir Sarcevic

Vice President/Chief Financial Officer

## Ex-97

**Exhibit 97**

![logo.jpg](logo.jpg)

**COMPENSATION CLAWBACK POLICY**

Legal

Revised: 8/15/2023

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**I.**  **<u>Introduction</u>** 

Standex International Corporation ("Standex" or the "Company") has adopted this policy in order (i) to comply with applicable rules of the Securities Exchange Commission and New York Stock Exchange listing standards implemented pursuant to section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. and (ii) to ensure that incentive-based compensation paid by Standex is based upon accurate financial data.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**II.**  **<u>Applicability</u>** 

This policy applies to any current or former Executive Officers (as defined below) of Standex.

This policy applies if Standex is required to prepare a Financial Restatement (as defined below).

This policy applies to all Incentive-Based Compensation (as defined below) that was erroneously awarded and received by an Executive Officer during the Recovery Period (as defined below).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**III.**  **<u>Definitions</u>** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**A.**  **<u>Who is an</u>** <u>"</u>  **<u>Executive Officer</u>** <u>"</u>  **<u>?</u>** 

Any person who is (or was, during the relevant time period) any one of the following: the president, principal financial officer, principal accounting officer, controller, any business unit president, any vice president in charge of a principal business unit, division or function, and any other officer who performs a policy-making function for Standex.

Executive officers of Standex's subsidiary companies are deemed Executive Officers of Standex if they perform policy making functions for Standex.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**B.**  **<u>What is a</u>** <u>"</u>  **<u>Financial Restatement</u>** <u>"</u>  **<u>?</u>** 

A Financial Restatement is an accounting restatement due to the Company's material noncompliance with any financial reporting requirement under the securities laws that either (A) corrects an error in previously issued financial statements that is material to the previously issued financial statements; or (B) corrects an error in previously issued financial statements that is not material to the previously issued financial statements, but would result in a material misstatement (i) if the error was left uncorrected in the current period or (ii) if the error correction was recognized in the current period financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**C.**  **<u>What is</u>** <u>"</u>  **<u>Incentive-Based Compensation</u>** <u>"</u>  **<u>?</u>** 

Incentive-Based Compensation is any compensation that is granted, earned or vested based wholly or partially upon the attainment of any financial reporting measure.

Financial reporting measures are defined as measures that are determined and presented in accordance with the accounting principles used in preparing Standex's financial statements, and any measures derived wholly or in part from such measures, including non-GAAP financial measures, as well as stock price and total shareholder return.

Examples include, but are not limited to:

● Non-equity incentive plan awards (cash awards) that are earned based wholly or in part on satisfying a financial reporting measure performance goal;

------

● Restricted stock, restricted stock units, performance share units, stock options and stock appreciation rights that are granted or become vested based wholly or in part on satisfying a financial reporting measure performance goal; and

● Proceeds received upon the sale of shares acquired through an incentive plan that were granted or vested based wholly or in part on satisfying a financial reporting measure performance goal.

Incentive-Based Compensation does not include base annual salary, compensation which is awarded based purely on service with Standex (such as time-based vesting of restricted stock), compensation which is awarded solely at the discretion of the Board of Directors, or compensation which is awarded based on subjective standards, strategic measures or operational measures.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**D.**  **<u>What is the</u>** <u>"</u>  **<u>Recovery Period</u>** <u>"</u>  **<u>?</u>** 

The Recovery Period is the three most recently completed fiscal years preceding the date on which Standex is required to prepare the Financial Restatement.

The date on which Standex is required to prepare the Financial Restatement is the earlier of: (1) the date Standex's Board of Directors (or the officer or officers authorized to do so if no Board action is required) concludes, or reasonably should have concluded, that Standex must prepare a Financial Restatement or (2) the date a court, regulator or other legally authorized body directs Standex to prepare a Financial Restatement.

---

| | |
|:---|:---|
| **IV.<u> </u>** | **<u>Recovery and Calculation of Erroneously awarded Incentive-Based</u> <u>Compensation; Disclosure</u>** |

---

In the event of a Financial Restatement, Standex shall recover reasonably promptly all Incentive- Based Compensation that has been erroneously received by a current and former Executive Officer during the Recovery Period, regardless of whether the Executive Officer was responsible for the cause of the Financial Restatement.

The recoverable amount is the amount of Incentive-Based Compensation received by the current or former Executive Officer that exceeds the amount of Incentive-Based Compensation that otherwise would have been received had it been determined based on the restated amounts as set forth in the Financial Restatement, without regard for any taxes paid.

For any Incentive-Based Compensation that was awarded and received based on TSR or stock price, where the amount of erroneously awarded compensation is not subject to mathematical recalculation directly from the information in a Financial Restatement, the amount will be based on a reasonable estimate of the effect of the Financial Restatement on the applicable measure.

The Compensation Committee of the Board of Directors shall have sole authority to determine the calculation of erroneously awarded compensation and shall be empowered to employ such resources as may be reasonably necessary in order to recoup such compensation. All such calculations shall be maintained in the Company's records and provided, upon request, to the SEC and/or NYSE.

The Compensation Committee shall determine, in its sole discretion, the timing and method for promptly recouping Erroneously Awarded Compensation hereunder, which may include without limitation (a) seeking reimbursement of all or part of any cash or equity-based award, (b) cancelling prior cash or equity-based awards, whether vested or unvested or paid or unpaid, (c) cancelling or offsetting against any planned future cash or equity-based awards, (d) forfeiture of deferred compensation, subject to compliance with Section 409A of the Internal Revenue Code and the regulations promulgated thereunder and (e) any other method authorized by applicable law or contract. Subject to compliance with any applicable law, the Compensation Committee may affect recovery under this Policy from any amount otherwise payable to the Executive Officer, including amounts payable to such individual under any otherwise applicable Company plan or program, including base salary, bonuses or commissions and compensation previously deferred by the Covered Executive.

------

The Company, as required by and in the form specified by applicable rules, shall disclose any actual clawback trigger, the amount recovered, the estimates used and the individuals from whom recovery is made.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**V.**  **<u>Exceptions to Recovery</u>** 

Standex is authorized and directed pursuant to this Policy to recoup Erroneously Awarded Incentive Compensation in compliance with this Policy <u>unless</u> the Compensation Committee has determined that recovery would be impracticable solely for the following limited reasons, and subject to the following procedural and disclosure requirements:

● The direct expense paid to a third party to assist in enforcing the Policy would exceed the amount to be recovered. Before concluding that it would be impracticable to recover any amount of Erroneously Awarded Compensation based on expense of enforcement, the Compensation Committee must make a reasonable attempt to recover such erroneously awarded compensation, document such reasonable attempt(s) to recover and provide that documentation to NYSE;

● Recovery would violate home country law of the issuer where that law was adopted prior to November 28, 2022. Before concluding that it would be impracticable to recover any amount of Erroneously Awarded Incentive Compensation based on violation of home country law of the issuer, the Compensation Committee must satisfy the applicable opinion and disclosure requirements of SEC Rule 10D-1 and the NYSE Listing Standards; or

● Recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of 26 U.S.C. 401(a)(13) or 26 U.S.C. 411(a) and regulations thereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**VI.**  **<u>No Additional Payments</u>** 

In no event shall Standex be required to award an Executive Officer additional payments if the Financial Restatement provides results that would have resulted in the receipt of higher Incentive- Based Compensation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**VII.**  **<u>No Indemnification of Executive Officers</u>** 

Notwithstanding the terms of any indemnification or insurance policy or any contractual arrangement with any Executive Officer that may be interpreted to the contrary, the Company shall not indemnify any Executive Officer against the loss of any Erroneously Awarded Compensation, including any payment or reimbursement for the cost of third-party insurance purchased by any Covered Executives to fund potential clawback obligations under this Policy.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**VIII.**  **<u>Effective Date and Application of the Policy</u>** 

This Policy shall be effective as of October 2, 2023 (the "Effective Date"). The terms of this Policy shall apply to any Incentive-Based Compensation that is received by an Executive Officer on or after the Effective Date, even if such Incentive-Based Compensation was approved, awarded, granted or paid to the Executive Officer prior to the Effective Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**IX.**  **<u>Amendment</u>** 

This policy may be amended by the Standex Board of Directors from time to time. Changes to this policy will be communicated to all applicable individuals.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**X.**  **<u>General</u>** 

The provisions of this policy are intended to be applied to the fullest extent of the law; provided however, to the extent that any provisions of this policy are found to be unenforceable or invalid under any applicable law, such provision will be applied to the maximum extent permitted and shall automatically be deemed amended in a manner consistent with its objectives to the extent necessary to conform to any limitations required under applicable law.

This policy is in addition to (and not in lieu of) any right of repayment, forfeiture or right of offset against any Executive Officer that is required pursuant to any statutory repayment requirement (regardless of whether implemented at any time prior to or following the adoption of this policy). Nothing in this policy in any way detracts from or limits any obligation that those subject to it have in law or pursuant to a management, employment, consulting or other agreement with Standex or any of its subsidiaries.

Questions concerning any aspect of this policy or its application should be directed to the Standex Legal Department.